Hepatic Insufficiency Global Clinical Trials Review, H1, 2015

Hepatic Insufficiency Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2642CTIDB
  • |
  • Pages: 75
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Hepatic Insufficiency Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Hepatic Insufficiency Global Clinical Trials Review, H1, 2015" provides data on the Hepatic Insufficiency clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatic Insufficiency. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatic Insufficiency. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Hepatic Insufficiency 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Hepatic Insufficiency to Gastrointestinal Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Hepatic Insufficiency to Gastrointestinal Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Hepatic Insufficiency 25

Subjects Recruited Over a Period of Time 26

Clinical Trials by Sponsor Type 27

Prominent Sponsors 28

Top Companies Participating in Hepatic Insufficiency Therapeutics Clinical Trials 29

Prominent Drugs 30

Clinical Trial Profiles 31

Clinical Trial Overview of Top Companies 31

Merck & Co., Inc. 31

Clinical Trial Overview of Merck & Co., Inc. 31

Novartis AG 32

Clinical Trial Overview of Novartis AG 32

Eli Lilly and Company 33

Clinical Trial Overview of Eli Lilly and Company 33

Puma Biotechnology, Inc. 34

Clinical Trial Overview of Puma Biotechnology, Inc. 34

Johnson & Johnson 35

Clinical Trial Overview of Johnson & Johnson 35

GlaxoSmithKline plc 36

Clinical Trial Overview of GlaxoSmithKline plc 36

C. H. Boehringer Sohn AG & Co. KG 37

Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 37

Pfizer Inc. 38

Clinical Trial Overview of Pfizer Inc. 38

Bristol-Myers Squibb Company 39

Clinical Trial Overview of Bristol-Myers Squibb Company 39

Astellas Pharma Europe Ltd. 40

Clinical Trial Overview of Astellas Pharma Europe Ltd. 40

Clinical Trial Overview of Top Institutes / Government 41

Copenhagen University Hospital Gentofte 41

Clinical Trial Overview of Copenhagen University Hospital Gentofte 41

National Cancer Institute 42

Clinical Trial Overview of National Cancer Institute 42

Aarhus University 43

Clinical Trial Overview of Aarhus University 43

Donau-Universitat Krems 44

Clinical Trial Overview of Donau-Universitat Krems 44

Huashan Hospital 45

Clinical Trial Overview of Huashan Hospital 45

Mayo Clinic 46

Clinical Trial Overview of Mayo Clinic 46

McGill University Health Center 47

Clinical Trial Overview of McGill University Health Center 47

Five Key Clinical Profiles 48

Appendix 73

Abbreviations 73

Definitions 73

Research Methodology 74

Secondary Research 74

About GlobalData 75

Contact Us 75

Disclaimer 75

Source 75

List of Figures

Hepatic Insufficiency Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Hepatic Insufficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Hepatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Hepatic Insufficiency Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Hepatic Insufficiency Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Hepatic Insufficiency Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Hepatic Insufficiency Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Proportion of Hepatic Insufficiency to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15

Hepatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Hepatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Hepatic Insufficiency to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18

Hepatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Hepatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Hepatic Insufficiency Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Hepatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Hepatic Insufficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Hepatic Insufficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Hepatic Insufficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26

Hepatic Insufficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27

Hepatic Insufficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28

Hepatic Insufficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Hepatic Insufficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

GlobalData Methodology 74

List of Tables

Hepatic Insufficiency Therapeutics, Global, Clinical Trials by Region, 2015* 7

Hepatic Insufficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Hepatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Hepatic Insufficiency Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Hepatic Insufficiency Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Hepatic Insufficiency Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Hepatic Insufficiency Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Hepatic Insufficiency Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Hepatic Insufficiency to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15

Hepatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Hepatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Hepatic Insufficiency to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18

Hepatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Hepatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Hepatic Insufficiency Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Hepatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Hepatic Insufficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Hepatic Insufficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Hepatic Insufficiency Therapeutics, Global, Terminated Clinical Trials, 2015* 25

Hepatic Insufficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26

Hepatic Insufficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27

Hepatic Insufficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28

Hepatic Insufficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Hepatic Insufficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 31

Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 32

Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015* 33

Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Puma Biotechnology, Inc., 2015* 34

Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015* 35

Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 36

Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2015* 37

Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 38

Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015* 39

Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Europe Ltd., 2015* 40

Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Copenhagen University Hospital Gentofte, 2015* 41

Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 42

Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2015* 43

Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Donau-Universitat Krems, 2015* 44

Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Huashan Hospital, 2015* 45

Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 46

Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by McGill University Health Center, 2015* 47

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Hepatic Insufficiency Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Hepatic Insufficiency, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

select a license

Single User License
USD 2500 INR 162625
Site License
USD 5000 INR 325250
Corporate User License
USD 7500 INR 487875

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com